• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对自身体重的认知偏差会显著增加非酒精性脂肪性肝病(NAFLD)的不良后果。

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD).

作者信息

Fu Clarissa Elysia, Ng Cheng Han, Chew Nicholas W S, Heng Zane En Qi, Chin Yip Han, Quek Jingxuan, Lim Wen Hui, Xiao Jieling, Chan Kai En, Tan Darren Jun Hao, Tan Caitlyn, Zhang Sitong, Koh Teng Kiat, Nah Benjamin, Dan Yock Young, Syn Nicholas, Siddiqui Mohammad Shadab, Sanyal Arun J, Noureddin Mazen, Muthiah Mark

机构信息

Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Department of Cardiology, National University Heart Centre, National University Hospital, Singapore, Singapore.

出版信息

Front Med (Lausanne). 2022 Sep 28;9:977552. doi: 10.3389/fmed.2022.977552. eCollection 2022.

DOI:10.3389/fmed.2022.977552
PMID:36250093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9554148/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is prevalent amongst overweight and obese individuals, and weight loss remains the main mode of treatment for NAFLD patients. Weight perception plays a key role in the efficacy of such treatment. The current study aims to investigate the prevalence, associating factors and implications of poor weight perception amongst such individuals.

METHODS

An analysis was done on data collected from NHANES between 1999 and 2018. Comparison was made between NAFLD individuals with and without poor weight perception in terms of prevalence, associated characteristics, and clinical outcomes. Multivariate analysis was used to compare effect size of adverse events associated with NAFLD individuals with poor weight perception.

RESULTS

Of the 12,170 NAFLD patients, 19.2% (CI: 18.5 to 19.9%) had poor weight perception. Poor weight perception was significantly associated with lower education levels, reduced levels of exercise and unhealthier lipid profiles. There was an increased risk in all-cause mortality (HR: 1.18, CI: 1.00 to 1.38, = 0.047), cardiovascular disease mortality (SHR: 1.33, CI: 1.03 to 1.71, = 0.026), major adverse cardiovascular events (OR: 1.21 CI: 1.10 to 1.32, < 0.001), and advanced fibrosis (OR: 1.30, CI: 1.03 to 1.64, = 0.025) for individuals with poor weight perception.

CONCLUSION

This study highlights the positive association between appropriate weight perception and better outcomes in individuals with NAFLD. Poor weight perception increased the risk of adverse events and decreased inclination toward seeking weight loss treatment. Greater emphasis should be placed on dealing with weight perception in individuals with NAFLD for better treatment outcomes.

摘要

背景

非酒精性脂肪性肝病(NAFLD)在超重和肥胖个体中普遍存在,体重减轻仍然是非酒精性脂肪性肝病患者的主要治疗方式。体重认知在这种治疗的疗效中起着关键作用。本研究旨在调查此类个体中体重认知不良的患病率、相关因素及其影响。

方法

对1999年至2018年美国国家健康和营养检查调查(NHANES)收集的数据进行分析。比较了体重认知良好和不良的非酒精性脂肪性肝病个体在患病率、相关特征和临床结局方面的差异。采用多变量分析比较体重认知不良的非酒精性脂肪性肝病个体不良事件的效应大小。

结果

在12170例非酒精性脂肪性肝病患者中,19.2%(95%置信区间:18.5%至19.9%)体重认知不良。体重认知不良与较低的教育水平、运动量减少和更不健康的血脂谱显著相关。体重认知不良的个体全因死亡率(风险比:1.18,95%置信区间:1.00至1.38,P = 0.047)、心血管疾病死亡率(标准化风险比:1.33,95%置信区间:1.03至1.71,P = 0.026)、主要不良心血管事件(比值比:1.21,95%置信区间:1.10至1.32,P < 0.001)和晚期肝纤维化(比值比:1.30,95%置信区间:1.03至1.64,P = 0.025)风险增加。

结论

本研究强调了非酒精性脂肪性肝病个体中适当的体重认知与更好结局之间的正相关关系。体重认知不良增加了不良事件的风险,并降低了寻求减肥治疗的意愿。为了获得更好的治疗效果,应更加重视非酒精性脂肪性肝病个体的体重认知问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/9554148/2a2700b3f43a/fmed-09-977552-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/9554148/2a2700b3f43a/fmed-09-977552-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c89d/9554148/2a2700b3f43a/fmed-09-977552-g0001.jpg

相似文献

1
A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD).对自身体重的认知偏差会显著增加非酒精性脂肪性肝病(NAFLD)的不良后果。
Front Med (Lausanne). 2022 Sep 28;9:977552. doi: 10.3389/fmed.2022.977552. eCollection 2022.
2
Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality.高血压在非酒精性脂肪性肝病中普遍存在,并增加全因死亡率和心血管疾病死亡率。
Front Cardiovasc Med. 2022 Aug 8;9:942753. doi: 10.3389/fcvm.2022.942753. eCollection 2022.
3
Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality.非酒精性脂肪性肝病中的抑郁与并发症和死亡率风险增加相关。
Front Med (Lausanne). 2022 Oct 6;9:985803. doi: 10.3389/fmed.2022.985803. eCollection 2022.
4
Non-alcoholic fatty liver disease is not associated with a lower health perception.非酒精性脂肪性肝病与较低的健康认知无关。
World J Gastroenterol. 2016 May 7;22(17):4362-72. doi: 10.3748/wjg.v22.i17.4362.
5
Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.20岁以后体重增加与正常体重个体非酒精性脂肪性肝病的关联。
J Gastroenterol Hepatol. 2015 May;30(5):909-17. doi: 10.1111/jgh.12861.
6
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
7
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.肌肉减少症和身体活动不足对非酒精性脂肪性肝病患者死亡率的影响。
JHEP Rep. 2020 Aug 15;2(6):100171. doi: 10.1016/j.jhepr.2020.100171. eCollection 2020 Dec.
8
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.全球非肥胖或消瘦非酒精性脂肪性肝病的患病率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):739-752. doi: 10.1016/S2468-1253(20)30077-7. Epub 2020 May 12.
9
Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.瘦型非酒精性脂肪性肝病(NAFLD)患者的临床特征和代谢特征及其与肥胖和超重 NAFLD 的比较。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
10
The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.非酒精性脂肪性肝病(NAFLD)与血清维生素 B12 标志物相关的肝纤维化程度的关联:来自 1999-2004 年 NHANES 的结果。
Nutrients. 2022 Mar 14;14(6):1224. doi: 10.3390/nu14061224.

引用本文的文献

1
General Public's knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population.公众对心脏代谢疾病的了解、认识及认知:来自新加坡研究人群的数据。
Front Med (Lausanne). 2023 Apr 24;10:1193829. doi: 10.3389/fmed.2023.1193829. eCollection 2023.
2
Socio-Demographic, Behavioral and Psychological Factors Associated with High BMI among Adults in a Southeast Asian Multi-Ethnic Society: A Structural Equation Model.社会人口学、行为和心理因素与东南亚多民族社会成年人的高 BMI 相关:结构方程模型。
Nutrients. 2023 Apr 10;15(8):1826. doi: 10.3390/nu15081826.
3
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019.

本文引用的文献

1
Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals.体重类别历史变化与非酒精性脂肪性肝病患病率的影响:34486 人人群分析。
Int J Environ Res Public Health. 2022 Aug 11;19(16):9935. doi: 10.3390/ijerph19169935.
2
Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease.非酒精性脂肪性肝病与心血管疾病的整体管理:全面综述与更新
Curr Atheroscler Rep. 2022 Jul;24(7):515-532. doi: 10.1007/s11883-022-01027-5. Epub 2022 May 4.
3
Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease.
204个国家和地区营养不良与肥胖的趋势及预测:基于2019年全球疾病负担研究的分析
EClinicalMedicine. 2023 Feb 16;57:101850. doi: 10.1016/j.eclinm.2023.101850. eCollection 2023 Mar.
非酒精性脂肪性肝病患者对体重状况和能量平衡行为的认知。
Sci Rep. 2022 Apr 5;12(1):5695. doi: 10.1038/s41598-022-09583-1.
4
Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis.Meta 分析:非酒精性脂肪性肝炎治疗机制途径的分析。贝叶斯网络荟萃分析证据。
Aliment Pharmacol Ther. 2022 May;55(9):1076-1087. doi: 10.1111/apt.16808. Epub 2022 Mar 14.
5
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD.一项关于MAFLD与NAFLD患病率及危险因素差异的观察性数据荟萃分析。
Clin Gastroenterol Hepatol. 2023 Mar;21(3):619-629.e7. doi: 10.1016/j.cgh.2021.11.038. Epub 2021 Dec 4.
6
Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease.脂肪肝与抑郁症有关吗?关于抑郁症和非酒精性脂肪性肝病的患病率、危险因素及后果的荟萃分析和系统评价
Front Med (Lausanne). 2021 Jun 30;8:691696. doi: 10.3389/fmed.2021.691696. eCollection 2021.
7
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults.估算超重或肥胖成年人代谢功能障碍相关脂肪性肝病的全球患病率。
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e573-e582. doi: 10.1016/j.cgh.2021.02.030. Epub 2021 Feb 20.
8
Discrepancies between actual weight, weight perception and weight loss intention amongst persons with NAFLD.非酒精性脂肪性肝病患者的实际体重、体重感知和减肥意愿之间的差异。
J Intern Med. 2021 Jun;289(6):840-850. doi: 10.1111/joim.13203. Epub 2020 Dec 19.
9
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals.非酒精性脂肪性肝病与新发糖尿病风险:对501022名成年人的最新荟萃分析
Gut. 2021 May;70(5):962-969. doi: 10.1136/gutjnl-2020-322572. Epub 2020 Sep 16.
10
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.非酒精性脂肪性肝病与心血管疾病风险增加:临床关联、病理生理机制及药理学意义
Gut. 2020 Sep;69(9):1691-1705. doi: 10.1136/gutjnl-2020-320622. Epub 2020 Apr 22.